Alexander Treiber

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Molecular Docking

Structure Activity Relationship

Top Venues

RSC medicinal chemistry

Pharmacology research & perspectives

This page only lists publications with an associated author ORCID identifier.

Publications

Benjamin Berger, Priska Kaufmann, Matthias Berse, Alexander Treiber, Nathalie Grignaschi, Jasper Dingemanse
Effect of nivasorexant (ACT-539313), a selective orexin-1-receptor antagonist, on multiple cytochrome P450 probe substrates in vitro and in vivo using a cocktail approach in healthy subjects. Pharmacology research & perspectives 11 (5) (2023)
Christine Brotschi, Martin H Bolli, John Gatfield, Catherine Roch, Thierry Sifferlen, Alexander Treiber, Jodi T Williams, Christoph Boss
Pyrazole derivatives as selective orexin-2 receptor antagonists (2-SORA): synthesis, structure-activity-relationship, and sleep-promoting properties in rats. RSC medicinal chemistry 15 (1) (2023)
Christine Brotschi, Martin H Bolli, John Gatfield, Catherine Roch, Thierry Sifferlen, Alexander Treiber, Jodi T Williams, Christoph Boss
Pyrazole derivatives as selective orexin-2 receptor antagonists (2-SORA): synthesis, structure-activity-relationship, and sleep-promoting properties in rats. RSC medicinal chemistry 15 (1) (2023)
Alexander Treiber, Stephane Delahaye, Swen Seeland, Carmela Gnerre
The endothelin receptor antagonist macitentan for the treatment of pulmonary arterial hypertension: A cross-species comparison of its cytochrome P450 induction pattern. Pharmacology research & perspectives 8 (4) (2021)